Background: Endothelial activation and dysfunction are associated with several diseases.
INTRODUCTION
In physiological conditions, endothelial cells (EC) play an important role in homeostasis of the blood. This homeostasis is lost during pathological conditions, at least in part by increased exposure of procoagulant and proadhesive antigens on their surface.
For example, only activated EC expose tissue factor (TF), the initiator of coagulation in vivo, and E-selectin, which facilitates reversible adhesion of white blood cells as part of the inflammatory response [1] [2] [3] [4] . Endothelial dysfunction is associated with several disease states such as preeclampsia, thrombotic thrombocytopenic purpura (TTP), diabetes, systemic lupus erythematosus (SLE), lupus anticoagulant, atherosclerosis, inflammation, hypertension, and coronary artery disease [5] [6] [7] [8] [9] [10] . At present, there are only a few markers for the detection of endothelial activation and/or dysfunction ex vivo such as von Willebrand Factor (vWF) and soluble (s) E-selectin [11] [12] [13] .
In vitro, activated EC show surface blebbing and the subsequent shedding of small vesicles (microparticles; MP) [14] [15] [16] [17] [18] . Recent studies report the presence of endothelial cell-derived microparticles (EMP) in peripheral blood from patients with lupus anticoagulant, TTP, acute coronary syndromes, and even in blood of healthy individuals [14, 15, 19] . However, in most studies the identification of EMP was based on the presence of surface antigens that are not exclusively exposed on EC, such as the platelet-endothelial cell adhesion molecule-1 (PECAM-1; CD31) or the vitronectin receptor ( 3 ; : CD51, 3 : CD61). In addition, a recent study showed that MP from human erythrocytes significantly differed in their antigenic composition from their corresponding parent cells [20] . Thus, a comprehensive characterization of the antigenic composition of EMP is required to accurately identify such vesicles in mixed populations of MP of various cellular origins as present in, for example, the venous blood of healthy individuals and patients. The aim of the present study was to compare the antigenic phenotype of EC and EMP under resting and activation conditions to establish reliable markers to quantify EMP.
MATERIALS AND METHODS

Reagents and assays
Medium M199, penicillin, streptomycin, and L-glutamine were obtained from MedSystems Diagnostics GmbH (Vienna, Austria). Recombinant human interleukin (IL)-1, human recombinant basic fibroblast growth factor (bFGF), and epidermal growth factor (EGF) were from GibcoBRL (Gaithersburg, MD, USA). Annexin V-(allophycocyanin; APC) was from Caltag Laboratories (Burlingame, CA, USA), collagenase (type 1A) from Sigma (St. Louis, MO, USA), ethylenediamine tetra-acetic acid (EDTA) from Merck (Darmstadt, Germany), heparin (400 U/mL) from Bufa BV (Uitgeest, The Netherlands), calcium ionophore A23187 from Calbiochem (Darmstadt, Germany), and trypsin from Difco Laboratories (Detroit, MI, USA). Human serum was provided by the Blood Bank Center (Leiden University Medical Center) and was heat inactivated during 30 minutes at 56 ºC (HuSi). Tissue culture flasks were from Greiner Labortechnik (Frickenhausen, Germany) and gelatin from Difco Laboratories (Sparks, MD, USA).
Isolation and culture of human umbilical vein endothelial cells
Human umbilical vein endothelial cells (HUVEC) were collected from human umbilical cord veins by minor modifications of previously described protocols [21, 22] .
Briefly, umbilical cords were filled with 1 mg/mL collagenase in M199 and subsequently incubated in phosphate-buffered saline (PBS) (154 mmol/L NaCl, 1.4 mmol/L phosphate; 
Flow cytometric analysis
MP samples were analyzed in a FACSCalibur flow cytometer (BD; San Jose, CA).
Forward scatter (FSC) and side scatter (SSC) were set at logarithmic gain and MP were identified as described previously [24, 25] . MP were identified on FSC, SSC, and binding of a MoAb. More than 80% of the events identified using these criteria also stained for annexin V (data not shown). 
Patients and healthy controls
In the present study, 11 SLE patients (all women) were included, all of whom fulfilled the revised criteria of the American College of Rheumatology for the diagnosis of SLE [26] . Their age was 42 years (median; range 23-64). The SLE Disease Activity Index [27] was 9 (median; range 0-22). As controls, 10 age-matched women were included. The study fulfilled the guidelines of the Medical Ethical Committee of the Slotervaart
Hospital.
Statistical analysis
Data were analyzed with Prism (3.02) for Windows. For direct comparison of the binding of MoAbs to HUVEC and EMP, paired t-tests were used. To compare the differences in MoAb binding to plasma samples from SLE patients and healthy volunteers, the Mann-Whitney U test was used. Two-tailed significance levels (P) are presented. Differences were considered statistically significant at P<0.05.
RESULTS
Antigenic exposure of resting and IL-1 -activated HUVEC
HUVEC were incubated for various time intervals up to 72 hours with and without IL-1 (5 ng/mL). Figure 1 shows representative dot plots of the surface antigen exposure of PECAM-1 and E-selectin. Both resting ( Figure 1A ) and activated ( Figure 1B ) HUVEC exposed PECAM-1. In contrast, E-selectin was exposed only on the activated HUVEC ( Figure 1D versus 1C) . The overall data are summarized in Figure 2 and in Table 1 . As is evident from Figure 2 , PECAM-1 (CD31), (CD51), and 3 (CD61) are exposed on all HUVEC independent of their activation status ( Figure 2B , D, F). About 20% of the resting HUVEC exposed TF ( Figure 2J ), whereas E-selectin was not exposed ( Figure 2H ).
Three hours after addition of IL-1 (the first measuring period), HUVEC exposed TF and E-selectin. The exposure of both antigens was transient and gradually diminished after 12 
ICAM-1 (CD54) was characterized on HUVEC and EMP from three other umbilical
cords.
Antigen exposure on EMP
Next, the antigen exposure on EMP, obtained from resting and activated HUVEC, was analyzed 12 hours after addition of IL-1 . Figure 3 shows that a subpopulation of EMP from resting and stimulated HUVEC exposed PECAM-1 ( Figure 3A, B) .
Approximately 20%-30% of the EMP, released from resting HUVEC, exposed PECAM-1. Upon activation, the percentage of PECAM-1-exposing EMP increased to almost 60%
( Figure 3B ). Figure 3C , D show the exposure of E-selectin on EMP from resting ( Figure   3C ) and activated ( Figure 3D ) HUVEC. Whereas EMP from resting HUVEC hardly stained for E-selectin ( Figure 3C ), EMP from HUVEC strongly stained for this antigen upon cell activation. Figure 4 summarizes the exposure of PECAM-1, , 3 , E-selectin and TF on EMP from resting and IL-1 -activated HUVEC. The antigens that were constitutively exposed on the HUVEC (PECAM-1, and 3 ), were exposed only on a subpopulation of the EMP (PECAM-1, ) or even absent ( 3 ). The antigens that were inducible on the HUVEC, i.e. E-selectin and TF, were virtually absent on EMP derived from resting HUVEC, but as also shown in Figure 3 , the EMP from activated HUVEC strongly exposed E-selectin up to 72 hours. On these EMP, TF was present but barely detectable by flow cytometry. Table 1 Comparison of the antigenic profile of PMP prepared in vitro with EMP Subsequently, we compared the antigenic profile of EMP and PMP prepared in vitro ( Figure 5 ). Both EMP and PMP exposed PECAM-1 ( Figure 5A and B, respectively). In contrast to the EMP, PMP strongly stained for GPIb (CD42b), GPIIIa (CD61) and Pselectin (CD62P) ( Figure 5C , G, K versus D, H, L, respectively).
PECAM-1 was exposed on a subpopulation of EMP during resting (panel A) and activated (B) conditions, whereas E-selectin was detectable only upon activation with IL-1 (D versus C). The fluorescence thresholds were set independently for EMP
(CD51) was nearly absent on EMP ( Figure 5E ) and PMP ( Figure 5F ). The only marker that positively and selectively identified EMP was E-selectin ( Figure 5I ), which was absent on PMP ( Figure   5J ).
Detection of EMP and PMP in plasma samples of SLE patients and healthy individuals
Based on our current observations, we reinvestigated the presence of EMP and PMP in plasma samples from patients with SLE and healthy individuals. In order to detect EMP and PMP in these samples, MP were isolated and stained with combinations of MoAbs directed against and E-selectin, and GPIb and GPIIIa, respectively. had previously been used to quantify MP [14] . As shown in Table 2 , most by far of the cell-derived MP in plasma samples studied from SLE patients and controls (median 66%) strongly stained for GPIb (CD42b), GPIIIa (CD61), or a combination of these two MoAbs. In contrast, hardly any MP stained for either , E-selectin, or a combination of these two MoAbs 
DISCUSSION
The present finding that the antigenic phenotype of EMP differs considerably from the HUVEC suggests that a sorting of membrane proteins occurs during membrane vesiculation. Interestingly, a recent study showed that calcium ionophore-activated erythrocytes release microparticles that antigenically differ from their parent cells [20] .
The selective sorting of membrane proteins into MP is likely to be a general phenomenon, which is not cell type specific.
In vitro cultured endothelial cells not only release MP upon activation with IL-1 , but also upon activation with tumour necrosis factor (TNF)- [14, 15, 17] , TNF-with cycloheximide or camptothecin [18] , or lipopolysaccharide [16] . [14, 15, 19] . In our present study, however, we found and 3 only exposed on a minor subpopulation ( ) or absent ( 3 ) on EMP prepared in vitro. Our present findings confirm earlier reports on the occurrence of EMP in vivo. However, earlier studies in which PECAM-1 plus , or PECAM-1 plus 3 were used to detect EMP ex vivo, may have overestimated their presence, since most of the MP ex vivo are of platelet origin which expose high levels of PECAM-1 and 3 .
In agreement with Combes et al [14] , we also found no evidence for E-selectinexposing EMP in plasma samples of SLE patients and healthy individuals. There was one exception, however. One patient, actually the one with the highest SLE disease activity index in our study, had a subpopulation of E-selectin-exposing MP, suggesting that in this particular patient the endothelium may have been more activated than in the other patients. However, this could not be confirmed because we measured the plasma concentration of vWF and found it in this patient to be not significantly higher than in other SLE patients (data not shown). We have no explanation yet for the low percentage PMP in the plasma of this SLE patient when compared to other SLE patients. Our present findings suggest that part of the soluble E-selectin, which is known to be elevated in plasma of patients with SLE, is MP-associated. Whether this E-selectin originates from the parent cell during MP formation or resembles originally soluble E-selectin subsequently bound to the MP from other cells, is also open for discussion. Only some 12% of the E-selectin-positive MP exposed , which supports our in vitro data that this is not a proper marker for EMP detection ex vivo. Since we found E-selectin exposing MP in plasma from only one out of 11 SLE patients, we also analysed plasma samples from severely Dengue virus infected patients. These patients are know to suffer from increased vascular permeability [29] and sera from such patients contain antibodies that directly trigger endothelial damage [30] . We found that plasma from two of these three patients contained a subpopulation of 8% and 17% of E-selectin exposing MP. About 90% of this subpopulation did not double stain for (data not shown). These data support our finding that may not be a proper marker to detect EMP.
Like E-selectin, TF was strongly inducible on the HUVEC. The exposure of TF peaked at 12 hours and diminished afterwards. Despite the fact that only a small subpopulation of EMP exposing TF was observed, reconstitution of these EMP strongly generated TF-and factor VII(a)-mediated thrombin generation in plasma (data not shown). This indicates that functional TF must be exposed on these vesicles. Possibly, the antigenic density, i.e. the number of exposed TF molecules, is too low to be detected by flow cytometry. Of course, this may also hold true for all other surface markers in the present study.
We also studied the exposure of GPIb (CD42b) on HUVEC (data not shown). Two different MoAbs failed to detect exposure of this antigen. However, a third MoAb gave conflicting results. Therefore, we are uncertain about the exposure of GPIb on HUVEC.
The present study shows that (i) EMP are released from HUVEC, (ii) the antigenic surface
